tiprankstipranks
Trending News
More News >
Star Health & Allied Insurance Co. Ltd. (IN:STARHEALTH)
:STARHEALTH
India Market
Advertisement

Star Health & Allied Insurance Co. Ltd. (STARHEALTH) AI Stock Analysis

Compare
1 Followers

Top Page

IN:STARHEALTH

Star Health & Allied Insurance Co. Ltd.

(STARHEALTH)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 4o)
Rating:69Neutral
Price Target:
₹489.00
▲(2.14% Upside)
Star Health & Allied Insurance Co. Ltd. demonstrates strong financial performance with consistent revenue growth and improved profitability, which significantly contributes to the overall score. The technical analysis supports a positive trend, although the valuation indicates the stock may be overvalued. The absence of earnings call data and corporate events means these factors do not influence the score.

Star Health & Allied Insurance Co. Ltd. (STARHEALTH) vs. iShares MSCI India ETF (INDA)

Star Health & Allied Insurance Co. Ltd. Business Overview & Revenue Model

Company DescriptionStar Health and Allied Insurance Company Limited provides health insurance products. It offers retail health products to various customer segments, including individuals, families, students, and senior citizens, as well as persons with pre-existing medical conditions across the middle-market customer segment; and group health insurance policies provide to employees of corporates, including SMEs through company health insurance plans. The company also provides personal accident and travel insurance. It distributes its products through individual agents, brokers, corporate agent banks, other corporate agents, and online channel partners comprising web aggregators, as well as directly to customers. As of September 30, 2021, the company had 779 health insurance branches across 25 states and 5 union territories in India. Star Health and Allied Insurance Company Limited was incorporated in 2005 and is based in Chennai, India.
How the Company Makes MoneyStar Health & Allied Insurance Co. Ltd. makes money primarily through the sale of insurance policies. The company's revenue model is based on collecting premiums from policyholders, which forms the bulk of its income. Key revenue streams include individual health insurance plans, group health insurance policies for corporates, and specialized products like personal accident and travel insurance. Additionally, the company earns investment income from the premiums collected, which are invested in various financial instruments. Partnerships with hospitals and healthcare providers enhance its service offerings, contributing to customer retention and acquisition. The company's financial performance is influenced by factors such as claim ratios, policy renewal rates, and regulatory changes in the insurance sector.

Star Health & Allied Insurance Co. Ltd. Financial Statement Overview

Summary
Star Health & Allied Insurance Co. Ltd. presents a strong financial position with consistent revenue growth and improving profitability metrics. The company has successfully reduced leverage, enhanced equity returns, and maintained solid cash flows, indicating financial stability and operational efficiency. While past challenges were evident in initial years, the recent improvements signal a positive trajectory for future performance.
Income Statement
75
Positive
Star Health & Allied Insurance Co. Ltd. has demonstrated a solid growth trajectory with Total Revenue increasing consistently over the years, from 2020 to 2025. The Gross Profit Margin remains strong at 100% consistently, indicating excellent cost management. Net Profit Margin has improved significantly from negative in 2021 to positive 4.01% in 2025, showcasing a successful turnaround. The EBIT and EBITDA margins have also improved, reflecting better operational efficiency. However, the initial years saw negative EBIT and EBITDA, indicating past challenges.
Balance Sheet
70
Positive
The company maintains a healthy Debt-to-Equity Ratio, declining from 0.15 in 2020 to 0.07 in 2025, demonstrating reduced leverage and improved financial stability. The Return on Equity has turned positive in recent years, reaching 9.08% in 2025, indicating effective use of shareholder capital. The Equity Ratio remains strong, showcasing a stable financial structure. However, initial high leverage in past years posed risks.
Cash Flow
80
Positive
Star Health has shown robust cash flow management with Operating Cash Flow consistently exceeding Net Income, indicating strong cash-generating abilities. The Free Cash Flow has exhibited growth, reflecting efficient capital expenditure management. The Operating Cash Flow to Net Income Ratio is stable, supporting a strong liquidity position. However, fluctuations in cash from investing activities in earlier years hint at past challenges.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue165.25B161.12B144.50B121.00B106.02B50.51B
Gross Profit165.25B161.12B144.50B122.41B106.02B50.51B
EBITDA6.41B8.61B12.68B9.67B-13.05B-9.72B
Net Income5.89B6.46B8.45B6.19B-10.41B-10.86B
Balance Sheet
Total Assets209.38B207.85B180.54B163.58B152.79B112.26B
Cash, Cash Equivalents and Short-Term Investments0.006.58B13.68B10.49B12.11B21.02B
Total Debt4.70B4.70B4.70B4.70B7.20B2.50B
Total Liabilities132.71B136.72B113.23B97.69B88.83B70.09B
Stockholders Equity76.67B71.12B67.32B65.89B63.96B42.17B
Cash Flow
Free Cash Flow0.0012.96B11.86B12.29B-340.86M8.19B
Operating Cash Flow0.0013.79B13.10B12.76B290.43M8.65B
Investing Cash Flow0.00-11.51B-11.77B-10.97B-37.86B-24.18B
Financing Cash Flow0.00-42.00M229.73M-2.68B25.36B26.39B

Star Health & Allied Insurance Co. Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price478.75
Price Trends
50DMA
442.65
Positive
100DMA
442.80
Positive
200DMA
425.83
Positive
Market Momentum
MACD
3.24
Negative
RSI
57.69
Neutral
STOCH
88.09
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:STARHEALTH, the sentiment is Positive. The current price of 478.75 is above the 20-day moving average (MA) of 448.38, above the 50-day MA of 442.65, and above the 200-day MA of 425.83, indicating a bullish trend. The MACD of 3.24 indicates Negative momentum. The RSI at 57.69 is Neutral, neither overbought nor oversold. The STOCH value of 88.09 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:STARHEALTH.

Star Health & Allied Insurance Co. Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
₹372.49B69.680.04%15.42%10.66%
69
Neutral
₹281.51B47.7124.82%-33.01%
69
Neutral
₹74.43B21.260.47%16.94%4.90%
61
Neutral
₹96.45B259.5516.85%-29.57%
60
Neutral
₹182.79B30.311.16%8.20%-4.26%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:STARHEALTH
Star Health & Allied Insurance Co. Ltd.
478.75
-69.10
-12.61%
IN:APLLTD
Alembic Pharmaceuticals Limited
947.85
-211.45
-18.24%
IN:HCG
HealthCare Global Enterprises Ltd.
690.40
240.80
53.56%
IN:MARKSANS
Marksans Pharma Limited
181.55
-106.78
-37.03%
IN:MEDANTA
Global Health Limited
1,348.75
323.32
31.53%
IN:MEDIASSIST
Medi Assist Healthcare Services Limited
526.70
-141.20
-21.14%

Star Health & Allied Insurance Co. Ltd. Corporate Events

Star Health Insurance Achieves Robust Q1FY26 Growth
Jul 29, 2025

Star Health and Allied Insurance Co. Ltd. reported a strong financial performance for Q1FY26, with a 44% increase in Profit After Tax to INR 438 crore and a 13% growth in Gross Written Premium. The company attributes its success to prudent underwriting practices, improved claims service, and strategic investments in technology and digital channels, reinforcing its leadership in the retail health insurance sector.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 02, 2025